ERS collaborates with 3D Systems to provide simulation equipment for EBUS training centers

The European Respiratory Society (ERS) and 3D Systems have signed a collaboration agreement to provide simulation equipment and event services for training centers for use in the ERS Endobronchial Ultrasound (EBUS) Certified Training Program.

As a result of the agreement, 3D Systems' BRONCH Mentor hands-on simulator will be used at three ERS training centers, based in Heidelberg, Copenhagen and Amsterdam, during the first two parts of the EBUS training program.

Access to the equipment will assist in the development and assessment of practical EBUS skills; EBUS is a minimally invasive procedure that can be used on an outpatient basis to not only diagnose and stage lung cancer but also to assess mediastinal nodes for other diseases such as sarcoidosis, tuberculosis or metastases from extrathoracic malignancies.

Previously, more invasive and costly procedures such as mediastinoscopy were required to reach the same diagnosis. The EBUS technique uses ultrasound along with a bronchoscope to visualize the bronchial wall and the adjacent mediastinal structures, meanwhile enabling real-time ultrasound-guided aspirations.

Participants on the EBUS training program are taught to competently perform endobronchial ultrasound via simulated EBUS tasks and cases using the BRONCH Mentor, as well as to independently assess patient history and results; identify indications and contraindications; perform independent procedures; and to interpret results and draw conclusions.

Professor Jouke Annema, an EBUS program organizer, from the Academic Medical Center in Amsterdam, said: "We are pleased to have come to an agreement with 3D Systems to provide services and technology at our EBUS training centers across Europe. The collaboration provides a number of advantages for ERS; our training centers will be better equipped, and training program participants will be able to practice their endobronchial ultrasound skills using the most advanced simulation technology on the market."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New approach to stabilize RSV protein could lead to better vaccines